Small (≤ 2 cm) hepatocellular carcinoma in patients with chronic liver disease: comparison of gadoxetic acid-enhanced 3.0 T MRI and multiphasic 64-multirow detector CT.
about
Application of Different Imaging Methods in the Early Diagnosis of Primary Hepatic CarcinomaRecent Advances in Tumor Ablation for Hepatocellular CarcinomaJSH Consensus-Based Clinical Practice Guidelines for the Management of Hepatocellular Carcinoma: 2014 Update by the Liver Cancer Study Group of JapanGadolinium Ethoxybenzyl Diethylenetriamine Pentaacetic Acid (Gd-EOB-DTPA)-Enhanced Magnetic Resonance Imaging and Multidetector-Row Computed Tomography for the Diagnosis of Hepatocellular Carcinoma: A Systematic Review and Meta-analysisFocal liver lesions: Practical magnetic resonance imaging approachDiagnostic accuracy of gadoxetic acid-enhanced MR for small hypervascular hepatocellular carcinoma and the concordance rate of Liver Imaging Reporting and Data System (LI-RADS).Effect of hepatocyte-specific gadolinium-based contrast agents on hepatic fat-fraction and R2(⁎).New paradigm for management of hepatocellular carcinoma by imaging.Changes in risk of immediate adverse reactions to iodinated contrast media by repeated administrations in patients with hepatocellular carcinomaAdded value of Gd-EOB-DTPA-enhanced Hepatobiliary phase MR imaging in evaluation of focal solid hepatic lesions.Liver Transplantation for Hepatocellular Carcinoma beyond Milan Criteria: Multidisciplinary Approach to Improve Outcome.Liver-specific agents for contrast-enhanced MRI: role in oncological imaging.The utility of gadoxetic acid-enhanced magnetic resonance imaging in the surveillance for postoperative recurrence of hepatocellular carcinomaCurrent opportunities and challenges of magnetic resonance spectroscopy, positron emission tomography, and mass spectrometry imaging for mapping cancer metabolism in vivo.Solid liver masses: approach to management from the standpoint of a radiologist.P4 radiology of hepatobiliary diseases with gadoxetic acid-enhanced MRI as a biomarker.Consensus report from the 6th International forum for liver MRI using gadoxetic acid.Hepatobiliary MR contrast agents in hypovascular hepatocellular carcinoma.Comparison of gadoxetic acid-enhanced magnetic resonance imaging and contrast-enhanced computed tomography with histopathological examinations for the identification of hepatocellular carcinoma: a multicenter phase III study.MR imaging features of focal liver lesions in Wilson disease.Comparison between Computer Tomography and Magnetic Resonance Imaging in the Diagnosis of Small Hepatocellular CarcinomaQuantitative evaluation of Gd-EOB-DTPA uptake in focal liver lesions by using T1 mapping: differences between hepatocellular carcinoma, hepatic focal nodular hyperplasia and cavernous hemangiomaPrognostic performance of preoperative gadoxetic acid-enhanced MRI in resectable hepatocellular carcinoma.Study on the diagnosis of small hepatocellular carcinoma caused by hepatitis B cirrhosis via multi-slice spiral CT and MRI.Differentiation of small (≤2 cm) hepatocellular carcinomas from small benign nodules in cirrhotic liver on gadoxetic acid-enhanced and diffusion-weighted magnetic resonance images.Assessing patients with hepatocellular carcinoma meeting the Milan criteria: Is liver 3 tesla MR with gadoxetic acid necessary in addition to liver CT?MRI manifestations of hepatic perfusion disorders.Dynamic enhancement pattern of HCC smaller than 3 cm in diameter on gadoxetic acid-enhanced MRI: comparison with multiphasic MDCT
P2860
Q26773119-BF7701DA-B0C3-4A2C-907B-D703B17B2150Q26775418-4656E3A7-038E-4968-A345-85191D6729B4Q26797521-ADC6FF7E-6EFE-49E1-B290-EB284A7EB726Q26798636-AFD10063-A638-4AD6-B73D-08F236585314Q26799474-A59EFCD1-E877-4D6A-B67C-68E4CEA54FD2Q30100967-D17E7552-D033-4A7A-8656-C958EBDA80E0Q30303112-72FA3D69-81F1-42C3-9543-3D6513DC8921Q30448048-8B9D84C6-2335-4346-B8DB-36B0E80F47FDQ35009221-A59E3152-BDDA-4BC8-A075-ECEB68572554Q35056708-3778E7BF-6B3A-4528-88DA-9E271580CEAEQ36962089-BB07081F-9967-4977-BD3B-DF91DD377F26Q37487034-52364B66-0024-43F5-A908-47D8B86E0AAEQ37530575-146736A5-650E-4DE5-933E-E685EC86F4AEQ37644820-059414DC-5DDE-4257-8A9B-D4BC17CFA2CCQ38163485-5EE93882-DAC1-4EF2-89E4-2731CB2C6141Q38177850-3A521FFF-06A4-4AA0-BBEA-EE07D45ED052Q38219801-AA641A22-67A7-4BFD-ADB3-92AC85F90925Q38238010-32055FA1-C799-4B95-92E4-CBC96C11210FQ38541176-8D432341-6D93-4F8C-BECF-C4F4C497A691Q38817986-D55DF375-9F11-4321-9D8C-2DDDE22C8016Q42144062-68A73B85-C7DE-409D-A0BF-33D09BA2152CQ42371543-812B2B44-A5ED-45D8-A963-D18857117CE4Q44199365-F5808CC6-9A2A-477D-BE93-E8C520E56647Q49629726-C5D2F177-B42F-4A90-9459-AFF6221261B2Q53060683-9EE14A2E-CCA1-4C9E-B3EE-267364DECB49Q53092360-547150C9-8AF7-4650-9774-7FAA775B0171Q55342722-9530662B-1AFD-410A-986D-F2E3692F1D27Q59115810-55F8FF6C-AEE3-46DD-89F1-2ECD0528FAF1
P2860
Small (≤ 2 cm) hepatocellular carcinoma in patients with chronic liver disease: comparison of gadoxetic acid-enhanced 3.0 T MRI and multiphasic 64-multirow detector CT.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Small (≤ 2 cm) hepatocellular ...... hasic 64-multirow detector CT.
@ast
Small (≤ 2 cm) hepatocellular ...... hasic 64-multirow detector CT.
@en
type
label
Small (≤ 2 cm) hepatocellular ...... hasic 64-multirow detector CT.
@ast
Small (≤ 2 cm) hepatocellular ...... hasic 64-multirow detector CT.
@en
prefLabel
Small (≤ 2 cm) hepatocellular ...... hasic 64-multirow detector CT.
@ast
Small (≤ 2 cm) hepatocellular ...... hasic 64-multirow detector CT.
@en
P2093
P2860
P356
P1476
Small (≤ 2 cm) hepatocellular ...... hasic 64-multirow detector CT.
@en
P2093
P2860
P304
P356
10.1259/BJR/27727228
P407
P577
2011-12-13T00:00:00Z